Skip to content

Daniel Gaddy

    • 10h-indexImpact measure calculated using publication and citation counts. Updated daily.
    • 294CitationsNumber of citations received by Daniel's publications. Updated daily.

    Other IDs

    Co-authors (53)

    Publications (5)

    • A gradient-loadable <sup>64</sup>Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography

      • Lee H
      • Zheng J
      • Gaddy D
      • et al.
      N/AReaders
      21Citations
      Get full text
    • Cyclophosphamide-mediated tumor priming for enhanced delivery and antitumor activity of HER2-targeted liposomal doxorubicin (MM-302)

      • Geretti E
      • Leonard S
      • Dumont N
      • et al.
      N/AReaders
      23Citations
      Get full text
    • Pharmacologic IKK/NF-kappa;B inhibition causes antigen presenting cells to undergo TNFα dependent ROS-mediated programmed cell death

      • Tilstra J
      • Gaddy D
      • Zhao J
      • et al.
      N/AReaders
      5Citations
      Get full text
    • Multiscale kinetic modeling of liposomal doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors

      • Hendriks B
      • Reynolds J
      • Klinz S
      • et al.
      N/AReaders
      21Citations
      Get full text
    • Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles

      • Pejawar-Gaddy S
      • Rajawat Y
      • Hilioti Z
      • et al.
      N/AReaders
      34Citations
      Get full text